The authors regret that the following Patient Consent Statement was missing from the above article:
Patient Consent
All patients were informed that data can be used for research and QA purposes, and possibly used in scientific publications (anonymized).
The authors would like to apologise for any inconvenience caused.
Article info
Publication history
Published online: January 07, 2023
Identification
Copyright
© 2022 The Author(s). Published by Elsevier B.V. on behalf of European Society for Radiotherapy & Oncology.
User license
Creative Commons Attribution (CC BY 4.0) | How you can reuse 
Elsevier's open access license policy
Creative Commons Attribution (CC BY 4.0)
Permitted
- Read, print & download
- Redistribute or republish the final article
- Text & data mine
- Translate the article
- Reuse portions or extracts from the article in other works
- Sell or re-use for commercial purposes
Elsevier's open access license policy
ScienceDirect
Access this article on ScienceDirectLinked Article
- Evaluation of image-guided and surface-guided radiotherapy for breast cancer patients treated in deep inspiration breath-hold: A single institution experienceTechnical Innovations and Patient Support in Radiation Oncology Vol. 21
- PreviewRadiation therapy after lumpectomy has become the standard treatment for breast cancer patients. It reduces the risk of local recurrence with a factor of 3–4 compared to no radiotherapy [1]. Improvements in screening, local and systemic treatments have led to improved survival in all breast cancer patients, especially in low-risk groups. Quality of life and long-term radiation-related toxicity, such as cardiotoxicity and breast fibrosis, are therefore of major concern. Modern radiotherapy techniques enable dose reduction to the heart without compromising the dose coverage to the target.
- Full-Text
- Preview
